Tom is a Biopharma & Advanced Therapies Specialist within PM Group and has been in the industry for 15 years. Tom has supported clients across the entire facility lifecycle from masterplanning, concept deign, detail design and facility optimization. Tom focuses his time on Advanced Therapies, including Gene & Cell Therapy, and advanced biologics facilities.
The biotechnology sector is changing the pharmaceutical manufacturing environment: The trend toward personalized medicine is driving smaller batch sizes with higher production volumes. Digitization and integration of GXP computerized systems will...